We are live on ! Find out more
RXST icon

RxSight
RXST

212 hedge funds and large institutions have $1.21B invested in RxSight in 2024 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 85 increasing their positions, 61 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,042% more call options, than puts

Call options by funds: $19.8M | Put options by funds: $1.73M

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

39% more repeat investments, than reductions

Existing positions increased: 85 | Existing positions reduced: 61

2.11% more ownership

Funds ownership: 85.54% → 87.65% (+2.1%)

1% less funds holding

Funds holding: 214 → 212 (-2)

5% less first-time investments, than exits

New positions opened: 40 | Existing positions closed: 42

28% less capital invested

Capital invested by funds: $1.68B → $1.21B (-$464M)

Holders
212
Holders Change
-2
Holders Change %
-0.93%
% of All Funds
2.79%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
40
Increased
85
Reduced
61
Closed
42
Calls
$19.8M
Puts
$1.73M
Net Calls
+$18.1M
Net Calls Change
-$3.51M

Top Buyers

1
Citadel Advisors
Citadel Advisors
Florida
+$35.3M
2
Credit Agricole
Credit Agricole
France
+$26.7M
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$22.2M
4
Millennium Management
Millennium Management
New York
+$19.8M
5
DDC
DF Dent & Co
Maryland
+$19.1M

Top Sellers

1
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$51.9M
2
SPPAM
Summit Partners Public Asset Management
Massachusetts
-$34M
3
Invesco
Invesco
Georgia
-$26.9M
4
DCM
Driehaus Capital Management
Illinois
-$23.3M
5
NCGI
Next Century Growth Investors
Minnesota
-$18.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
VP
51
Vitruvian Partners
United Kingdom
$4.96M +$6.51M +144,300 New
Squarepoint
52
Squarepoint
New York
$4.58M +$667K +14,799 +13%
Ensign Peak Advisors
53
Ensign Peak Advisors
Utah
$4.57M +$1.26M +27,913 +27%
Two Sigma Advisers
54
Two Sigma Advisers
New York
$4.54M -$3.37M -74,800 -36%
Two Sigma Investments
55
Two Sigma Investments
New York
$4.38M -$6.98M -154,871 -55%
American Century Companies
56
American Century Companies
Missouri
$4.26M -$5.67M -125,757 -50%
GIM
57
Granahan Investment Management
Massachusetts
$4.13M +$8.43K +187 +0.2%
EGM
58
Engineers Gate Manager
New York
$3.66M +$605K +13,408 +14%
Bank of New York Mellon
59
Bank of New York Mellon
New York
$3.54M +$423K +9,385 +10%
SBF
60
Sara-Bay Financial
Florida
$3.38M -$405K -8,989 -8%
JF
61
Jump Financial
Illinois
$3.21M +$1.53M +33,934 +57%
SAM
62
Silvercrest Asset Management
New York
$2.99M +$3.92M +86,825 New
UBS AM
63
UBS AM
Illinois
$2.92M +$728K +16,140 +23%
GPGA
64
Grandeur Peak Global Advisors
Utah
$2.91M +$3.81M +84,560 New
AG
65
Algert Global
California
$2.87M +$874K +19,382 +30%
Jane Street
66
Jane Street
New York
$2.87M +$2.12M +47,012 +129%
FCBT
67
First Citizens Bank & Trust
North Carolina
$2.64M – – –
SW
68
SVB Wealth
Massachusetts
$2.64M +$3.46M +76,816 New
T. Rowe Price Investment Management
69
T. Rowe Price Investment Management
Maryland
$2.51M -$136K -3,006 -4%
Tudor Investment Corp
70
Tudor Investment Corp
Connecticut
$2.34M +$1.65M +36,669 +117%
Swiss National Bank
71
Swiss National Bank
Switzerland
$2.28M +$76.7K +1,700 +3%
Barclays
72
Barclays
United Kingdom
$2.23M +$272K +6,021 +10%
Citigroup
73
Citigroup
New York
$2.19M +$1.66M +36,754 +137%
TI
74
Trexquant Investment
Connecticut
$1.94M -$3.37M -74,813 -57%
4A
75
4D Advisors
California
$1.89M +$2.48M +55,000 New
1 2
3
4 5

RXST Hedge Fund Activity: Q4 2024 in Review

212 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in RxSight (RXST) for Q4 2024, worth a combined $1.21B — down 28% from $1.68B a quarter earlier.

Sellers outnumbered buyers: 42 funds closed out of RXST and 40 opened new positions — a net loss of 2 holders — while 61 trimmed existing stakes and 85 added.

The largest buyer was Citadel Advisors, adding an estimated $35.3M. The largest seller was Lord, Abbett & Co, exiting entirely with an estimated $51.9M sold.

  • 212 institutional investors held RxSight (RXST) as of Q4 2024, down from 214 in Q3 2024.
  • Funds reported $1.21B of RxSight stock for Q4 2024, down 28% quarter-over-quarter.
  • 40 funds opened new RxSight positions in Q4 2024 and 42 closed out, a net change of -2 holders.
  • The largest RxSight buyer in Q4 2024 was Citadel Advisors, an estimated $35.3M added.
  • The largest RxSight seller in Q4 2024 was Lord, Abbett & Co, an estimated $51.9M sold.

Based on aggregated 13F filings for Q4 2024.